Determining drug efficacy using plasmonically enhanced imaging of the morphological changes of cells upon death

Journal of Physical Chemistry Letters

Volumn 5, Issue 20, 2014, Pages 3514-3518

  Aioub, Mena ^a   Austin, Lauren A ^a   El Sayed, Mostafa A ^a  

^a GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

cell death; drug efficacy; gold nanoparticles; plasmonics; Rayleigh imaging

Indexed keywords

CELL CULTURE; CELL DEATH; DIAGNOSIS; FIBER OPTIC SENSORS; GOLD METALLOGRAPHY; GOLD NANOPARTICLES; LIGHT SCATTERING; METAL NANOPARTICLES; OPTICAL PROPERTIES; PLASMONIC NANOPARTICLES; PLASMONICS; RAYLEIGH SCATTERING; CELLS; GOLD; MORPHOLOGY; NANOPARTICLES;

APOPTOTIC CELL DEATH; CELL VIABILITY ASSAYS; CHEMOTHERAPEUTIC DRUGS; DIRECT OBSERVATIONS; DRUG EFFICACY; INEXPENSIVE EQUIPMENT; MORPHOLOGICAL CHANGES; RAYLEIGH IMAGING; GOLD NANOPARTICLES; PLASMONICS;

DRUG DELIVERY; CYTOLOGY;

EID: 84908067089     PISSN: None     EISSN: 19487185     Source Type: Journal    
DOI: 10.1021/jz501866g     Document Type: Article

References (26)

1. Dreaden, E. C.; Alkilany, A. M.; Huang, X. H.; Murphy, C. J.; El-Sayed, M. A. The Golden Age: Gold Nanoparticles for Biomedicine Chem. Soc. Rev. 2012, 41, 2740-2779
2. Jain, P. K.; Huang, X. H.; El-Sayed, I. H.; El-Sayed, M. A. Noble Metals on the Nanoscale: Optical and Photothermal Properties and Some Applications in Imaging, Sensing, Biology, and Medicine Acc. Chem. Res. 2008, 41, 1578-1586
3. Daniel, M. C.; Astruc, D. Gold Nanoparticles: Assembly, Supramolecular Chemistry, Quantum-Size-Related Properties, and Applications toward Biology, Catalysis, and Nanotechnology Chem. Rev. 2004, 104, 293-346
4. Giljohann, D. A.; Seferos, D. S.; Daniel, W. L.; Massich, M. D.; Patel, P. C.; Mirkin, C. A. Gold Nanoparticles for Biology and Medicine Angew. Chem., Int. Ed. 2010, 49, 3280-3294
5. El-Sayed, I. H.; Huang, X.; El-Sayed, M. A. Surface Plasmon Resonance Scattering and Absorption of Anti-EGFR Antibody Conjugated Gold Nanoparticles in Cancer Diagnostics: Applications in Oral Cancer Nano Lett. 2005, 5, 829-834
6. Kang, B.; Austin, L. A.; El-Sayed, M. A. Observing Real-Time Molecular Event Dynamics of Apoptosis in Living Cancer Cells Using Nuclear-Targeted Plasmonically Enhanced Raman Nanoprobes ACS Nano 2014, 8, 4883-4892
7. Liu, X.; Dai, Q.; Austin, L.; Coutts, J.; Knowles, G.; Zou, J. H.; Chen, H.; Huo, Q. A One-Step Homogeneous Immunoassay for Cancer Biomarker Detection Using Gold Nanoparticle Probes Coupled with Dynamic Light Scattering J. Am. Chem. Soc. 2008, 130, 2780-2782
8. Aioub, M.; Kang, B.; Mackey, M. A.; El-Sayed, M. A. Biological Targeting of Plasmonic Nanoparticles Improves Cellular Imaging via the Enhanced Scattering in the Aggregates Formed J. Phys.Chem. Lett. 2014, 5, 2555-2561
9. Evan, G.; Littlewood, T. A Matter of Life and Cell Death Science 1998, 281, 1317-1322
10. Holohan, C.; Van Schaeybroeck, S.; Longley, D. B.; Johnston, P. G. Cancer Drug Resistance: An Evolving Paradigm Nat. Rev. Cancer 2013, 13, 714-726
11. Brown, J. M.; Attardi, L. D. The Role of Apoptosis in Cancer Development and Treatment Response Nat. Rev. Cancer 2005, 5, 231-237
12. Fesik, S. W. Promoting Apoptosis as a Strategy for Cancer Drug Discovery Nat. Rev. Cancer 2005, 5, 876-885
13. Hsiang, Y. H.; Liu, L. F. Identification of Mammalian DNA Topoisomerase-I as an Intracellular Target of the Anticancer Drug Camptothecin Cancer Res. 1988, 48, 1722-1726
14. Siddik, Z. H. Cisplatin: Mode of Cytotoxic Action and Molecular Basis of Resistance Oncogene 2003, 22, 7265-7279
15. Li, M. H.; Ito, D.; Sanada, M.; Odani, T.; Hatori, M.; Iwase, M.; Nagumo, M. Effect of 5-Fluorouracil on G1 Phase Cell Cycle Regulation in Oral Cancer Cell Lines Oral Oncol. 2003, 40, 63-70
16. Otsuka, H.; Nagasaki, Y.; Kataoka, K. Pegylated Nanoparticles for Biological and Pharmaceutical Applications Adv. Drug Delivery Rev. 2003, 55, 403-419
17. Ghosh, P.; Han, G.; De, M.; Kim, C. K.; Rotello, V. M. Gold Nanoparticles in Delivery Applications Adv. Drug Delivery Rev. 2008, 60, 1307-1315
18. Castel, S.; Pagan, R.; Mitjans, F.; Piulats, J.; Goodman, S.; Jonczyk, A.; Huber, F.; Vilaro, S.; Reina, M. RGD Peptides and Monoclonal Antibodies, Antagonists of Alpha(V)-Integrin, Enter the Cells by Independent Endocytic Pathways Lab. Invest. 2001, 81, 1615-1626
19. Zitzmann, S.; Ehemann, V.; Schwab, M. Arginine-Glycine-Aspartic Acid (RGD)-Peptide Binds to Both Tumor and Tumor-Endothelial Cells in Vivo Cancer Res. 2002, 62, 5139-5143
20. Escriou, V.; Carriere, M.; Scherman, D.; Wils, P. NLS Bioconjugates for Targeting Therapeutic Genes to the Nucleus Adv. Drug Delivery Rev. 2003, 55, 295-306
21. Tkachenko, A. G.; Xie, H.; Liu, Y. L.; Coleman, D.; Ryan, J.; Glomm, W. R.; Shipton, M. K.; Franzen, S.; Feldheim, D. L. Cellular Trajectories of Peptide-Modified Gold Particle Complexes: Comparison of Nuclear Localization Signals and Peptide Transduction Domains Bioconjugate Chem. 2004, 15, 482-490
22. Xue, H.; Atakilit, A.; Zhu, W. M.; Li, X. W.; Ramos, D. M.; Pytela, R. Role of the αvβ6 Integrin in Human Oral Squamous Cell Carcinoma Growth in Vivo and in Vitro Biochem. Biophys. Res. Commun. 2001, 288, 610-618
23. Voet, D.; Voet, J. G.; Pratt, C. W. Fundamentals of Biochemistry: Life at the Molecular Level, 4 th ed.; Wiley: Hoboken, NJ, 2012.
24. Austin, L. A.; Kang, B.; El-Sayed, M. A. A New Nanotechnology Technique for Determining Drug Efficacy Using Targeted Plasmonically Enhanced Single Cell Imaging Spectroscopy J. Am. Chem. Soc. 2013, 135, 4688-4691
25. Jain, P. K.; Huang, W. Y.; El-Sayed, M. A. On the Universal Scaling Behavior of the Distance Decay of Plasmon Coupling in Metal Nanoparticle Pairs: A Plasmon Ruler Equation Nano Lett. 2007, 7, 2080-2088
26. Reinhard, B. M.; Siu, M.; Agarwal, H.; Alivisatos, A. P.; Liphardt, J. Calibration of Dynamic Molecular Ruler Based on Plasmon Coupling between Gold Nanoparticles Nano Lett. 2005, 5, 2246-2252